BackgroundCheck.run
Search For

Jeffrey R Watkins, 41Mount Airy, MD

Jeffrey Watkins Phones & Addresses

Mount Airy, MD   

Springfield, VA   

Lockport, NY   

Romulus, NY   

Ithaca, NY   

Whitehall, NY   

Collinsville, IL   

Marcellus, NY   

9521 Orion Ct, Burke, VA 22015    703-4513589   

Work

Company: Washington Address: 2041 Georgia Ave Nw, Washington, DC 20060 Phones: 202-8656100 (Phone) 202-8067022 (Fax)

Languages

English

Mentions for Jeffrey R Watkins

Career records & work history

Lawyers & Attorneys

Jeffrey Watkins Photo 1

Jeffrey Watkins - Lawyer

ISLN:
917018273
Admitted:
2001
University:
Drake University, B.S.B.A., 1994
Law School:
Georgia State University, J.D., 1997

Medicine Doctors

Jeffrey Watkins Photo 2

Dr. Jeffrey N Watkins, Washington DC - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
2041 Georgia Ave Nw, Washington, DC 20060
202-8066100 (Phone)
Washington
2041 Georgia Ave Nw, Washington, DC 20060
202-8656100 (Phone) 202-8067022 (Fax)
Languages:
English
Hospitals:
2041 Georgia Ave Nw, Washington, DC 20060
Washington
2041 Georgia Ave Nw, Washington, DC 20060
Howard University Hospital
2041 Georgia Avenue North West, Washington, DC 20060

Jeffrey W. Watkins

Specialties:
Cardiovascular Disease, Interventional Cardiology
Work:
Sanford Bemidji Clinic
1233 34 St NW, Bemidji, MN 56601
218-3335000 (phone) 218-3335433 (fax)
Sanford Health Of Northern Minnesota
1300 Anne St NW, Bemidji, MN 56601
218-7515430 (phone) 218-3332461 (fax)
Education:
Medical School
Virginia Commonwealth University SOM
Graduated: 1979
Procedures:
Angioplasty, Pacemaker and Defibrillator Procedures, Cardiac Catheterization, Cardiac Stress Test, Continuous EKG, Echocardiogram, Electrocardiogram (EKG or ECG)
Conditions:
Abdominal Aortic Aneurysm, Acute Myocardial Infarction (AMI), Anemia, Angina Pectoris, Aortic Regurgitation, Aortic Stenosis, Aortic Valvular Disease, Atherosclerosis, Atrial Fibrillation and Atrial Flutter, Cardiac Arrhythmia, Cardiomyopathy, Carditis, Chronic Renal Disease, Conduction Disorders, Congenital Anomalies of the Heart, Diabetes Mellitus (DM), Disorders of Lipoid Metabolism, Heart Failure, Hypertension (HTN), Ischemic Heart Disease, Ischemic Stroke, Mitral Stenosis, Mitral Valvular Disease, Osteoarthritis, Paroxysmal Supreventricular Tachycardia (PSVT), Raynaud's Disease, Valvular Heart Disease
Languages:
English
Description:
Dr. Watkins graduated from the Virginia Commonwealth University SOM in 1979. He works in Bemidji, MN and 1 other location and specializes in Cardiovascular Disease and Interventional Cardiology. Dr. Watkins is affiliated with Sanford Bemidji Medical Center.

Jeffrey W. Watkins

Specialties:
Podiatric Medicine
Work:
Castle Orthopaedics/Sport MedicalCastle Orthopaedics & Sports Medicine SC
1315 N Highland Ave STE 103, Aurora, IL 60506
630-8924286 (phone) 630-8920809 (fax)
Site
Castle Orthopaedics/Sport MedicalCastle Orthopaedics & Sports Medicine SC
507 W Kendall Dr STE 4, Yorkville, IL 60560
630-5533000 (phone) 630-8623086 (fax)
Site
Castle Orthopaedics/Sport MedicalCastle Orthopaedics & Sports Medicine
2111 Ogden Ave, Aurora, IL 60504
630-9783800 (phone) 630-8623086 (fax)
Site
Procedures:
Arthrocentesis, Hallux Valgus Repair
Conditions:
Plantar Fascitis, Hallux Valgus, Tinea Pedis
Languages:
English, Spanish
Description:
Dr. Watkins works in Aurora, IL and 2 other locations and specializes in Podiatric Medicine. Dr. Watkins is affiliated with Presence Mercy Medical Center and Rush Copley Medical Center.

Jeffrey Watkins

Specialties:
General Surgery
Work:
Methodist Dallas Medical Center General Surgery Residency
1441 N Beckley Ave, Dallas, TX 75203
214-9472315 (phone)
Education:
Medical School
University of Texas Southwestern Medical Center at Dallas
Graduated: 2011
Languages:
English
Description:
Dr. Watkins graduated from the University of Texas Southwestern Medical Center at Dallas in 2011. He works in Dallas, TX and specializes in General Surgery.
Jeffrey Watkins Photo 3

Jeffrey Nathaniel Watkins, Washington DC

Specialties:
Internal Medicine
Work:
Jeffrey A Stone
2041 Georgia Ave NW, Washington, DC 20060
Jeffrey Watkins Photo 4

Jeffrey Robert Watkins

Specialties:
Surgery

License Records

Jeffrey Watkins

Licenses:
License #: 63.89.0011 - Active
Issued Date: Aug 29, 2013
Expiration Date: Aug 28, 2017
Type: Ust Tank Installer
License #: 63.89.0011/1 - Active

Jeffrey Walter Watkins Md

Licenses:
License #: 24915 - Expired
Category: Medicine
Issued Date: Nov 13, 2008
Effective Date: Oct 12, 2010
Expiration Date: Oct 1, 2010
Type: Physician

Jeffrey Watkins resumes & CV records

Resumes

Jeffrey Watkins Photo 50

Jeffrey Watkins

Jeffrey Watkins Photo 51

Jeffrey Watkins

Education:
Purdue University
Jeffrey Watkins Photo 52

Jeffrey Watkins

Jeffrey Watkins Photo 53

Jeffrey Jeff Watkins

Jeffrey Watkins Photo 54

Jeffrey Watkins

Publications & IP owners

Us Patents

Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment

US Patent:
7553489, Jun 30, 2009
Filed:
Dec 20, 2006
Appl. No.:
11/643982
Inventors:
James F. Young - Potomac MD, US
Scott Koenig - Rockville MD, US
Leslie S. Johnson - Germantown MD, US
William D. Huse - Del Mar CA, US
Jeffrey D. Watkins - Encinitas CA, US
Herren Wu - Germantown MD, US
Assignee:
MedImmune, LLC - Gaithersburg MD
International Classification:
A61K 39/42
A61K 39/155
US Classification:
4241591, 4242111
Abstract:
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis of a RSV infection.

Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment

US Patent:
7847082, Dec 7, 2010
Filed:
Jun 1, 2009
Appl. No.:
12/476183
Inventors:
James F. Young - Potomac MD, US
Scott Koenig - Rockville MD, US
Leslie S. Johnson - Germantown MD, US
William D. Huse - Del Mar CA, US
Jeffrey D. Watkins - Encinitas CA, US
Herren Wu - Boyds MD, US
Assignee:
MedImmune, LLC - Gaithersburg MD
International Classification:
C07H 21/04
A61K 39/42
A61K 39/155
US Classification:
536 2353, 4241591, 4242111
Abstract:
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection.

Methods Of Administering/Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment

US Patent:
2005014, Jul 7, 2005
Filed:
Oct 8, 2004
Appl. No.:
10/962285
Inventors:
James Young - Potomac MD, US
Scott Koenig - Rockville MD, US
Leslie Johnson - Germantown MD, US
William Huse - Del Mar CA, US
Jeffrey Watkins - Encinitas CA, US
Herren Wu - Boyds MD, US
International Classification:
A61K039/42
C12Q001/70
C07H021/04
C12N005/06
C07K016/08
US Classification:
424159100, 435005000, 435069100, 435320100, 435339000, 530388300, 536023530
Abstract:
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection

Methods Of Administering / Dosing Anti-Rsv Antibodies For Prophylaxis And Treatment

US Patent:
2012007, Mar 22, 2012
Filed:
Oct 18, 2010
Appl. No.:
12/906948
Inventors:
JAMES F. YOUNG - POTOMAC MD, US
SCOTT KOENIG - ROCKVILLE MD, US
LESLIE S. JOHNSON - GERMANTOWN MD, US
WILLIAM D. HUSE - DEL MAR CA, US
JEFFREY D. WATKINS - ENCINITAS CA, US
HERREN WU - BOYDS MD, US
Assignee:
MEDIMMUNE, LLC - GAITHERSBURG MD
International Classification:
A61K 39/42
C12N 15/13
C07K 16/46
A61P 31/14
C12N 1/21
C12N 5/10
C12P 21/00
C12Q 1/70
C12N 1/19
C07K 16/10
C12N 15/63
US Classification:
4241591, 5303894, 536 2353, 5303873, 4353201, 435339, 435 696, 435 5, 435419, 4352542, 4352523
Abstract:
The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection

Isbn (Books And Publications)

The Nmda Receptor

Author:
Jeffrey C. Watkins
ISBN #:
0192625020

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.